The Leadership Team at Purespring Therapeutics is responsible for setting the strategic vision and direction of the company, focusing on advancing AAV gene therapies for kidney diseases. They collaborate on scientific and operational initiatives, driving research and development efforts while ensuring alignment with regulatory standards and market needs. Through their expertise, the team cultivates partnerships and fosters innovation to improve patient outcomes globally.
View all